Is Pramlintide (Symlin) legal?
Pramlintide (Symlin) is an FDA approved drug. For drug-tested athletes it is not on the WADA prohibited list. Yes, endocrinology providers prescribe in insulin-using diabetes contexts.. Legal status depends on your country and changes over time. This reflects US status at the time of writing and is not legal or medical advice.
Regulatory status
- FDA: Approved as Symlin (2005) as adjunct to mealtime insulin in T1D and T2D.
- WADA: Not listed
- Prescription: Yes, endocrinology providers prescribe in insulin-using diabetes contexts.
References
- Pramlintide as an adjunct to insulin therapy in T1D, review — Edelman SV et al., Diabetes Technol Ther, 2008
- Addition of pramlintide to insulin therapy lowers HbA1c in conjunction with weight loss in patients with type 2 diabetes approaching glycaemic targets — Hollander P et al., Diabetes, Obesity & Metabolism, 2003
- Pramlintide in the management of insulin-using patients with type 2 and type 1 diabetes — Pullman J et al., Vascular Health and Risk Management, 2006
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Pramlintide (Symlin)
Last updated 2026-06-06.